Daiwa Securities Group Inc. Adma Biologics, Inc. Transaction History
Daiwa Securities Group Inc.
- $23.7 Billion
- Q1 2025
A detailed history of Daiwa Securities Group Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 780 shares of ADMA stock, worth $13,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
780
Previous 780
-0.0%
Holding current value
$13,065
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
393Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$312 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$282 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$216 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$192 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$99 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...